Clinical Relevance of Single-Voxel 1 H Mrs Metabolites in Discriminating Suprasellar Tumors

Introduction: Spatially resolved metabolic data obtained from Proton Magnetic Resonance Spectroscopy (1 H MRS) provides information which increases the diagnostic accuracy of imaging sequences in predicting the histology of suprasellar tumors. Aim: To evaluate the role of 1 H MRS in the diagno...

Full description

Bibliographic Details
Main Authors: A EINSTIEN, RAHUL A VIRANI
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2016-07-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/8078/17988_CE[Ra]_F(P)_Reformat_PF2(PAG)_PFA(P).pdf
_version_ 1818308546649915392
author A EINSTIEN
RAHUL A VIRANI
author_facet A EINSTIEN
RAHUL A VIRANI
author_sort A EINSTIEN
collection DOAJ
description Introduction: Spatially resolved metabolic data obtained from Proton Magnetic Resonance Spectroscopy (1 H MRS) provides information which increases the diagnostic accuracy of imaging sequences in predicting the histology of suprasellar tumors. Aim: To evaluate the role of 1 H MRS in the diagnosis of various suprasellar tumors. Materials and Methods: Sixty cases of various suprasellar, hypothalamic and third ventricular neoplasms were investigated with long-echo single voxel 1 H -MRS using 1.5 Tesla clinical imager. Single-voxel spectroscopic examinations were guided by T1-weighted or T2-weighted images. Statistical analysis was carried out using IBM SPSS software version 19. Results: We observed that whenever brain tissue was damaged or replaced by any process, NAA was markedly reduced. Extraaxial lesions which do not infiltrate brain or contain neuroglial tissue, didn’t demonstrate any NAA resonances. Cr was used as an internal standard for semi-quantitative evaluation of metabolic changes of other brain metabolites. Increased Cho was seen in processes with elevated cell-membrane turnover. Conclusion: Spectra obtained from different tumors exhibit reproducible differences while histologically similar tumors yield characteristic spectra with only minor differences. Pituitary tumors were typically characterized by significant reduction of NAA, Cr peak and moderate elevation of Cho peak. Gliomas were typically characterized by decrease of NAA and Cr peaks and increase of Cho peak. Craniopharyngiomas were typically characterized by significant decrease of all metabolites.
first_indexed 2024-12-13T07:16:00Z
format Article
id doaj.art-da686cbb72dd48ceb4df5bfe6c0dff36
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-13T07:16:00Z
publishDate 2016-07-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-da686cbb72dd48ceb4df5bfe6c0dff362022-12-21T23:55:33ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2016-07-01107TC01TC0410.7860/JCDR/2016/17988.8078Clinical Relevance of Single-Voxel 1 H Mrs Metabolites in Discriminating Suprasellar TumorsA EINSTIEN0RAHUL A VIRANI1Assistant Professor, Department of Radiology, Chettinad Hospital & Research Institute, Kelambakkam, Tamil Nadu, India.Consultant, Department of Radiology, Horizon Imaging, Morbi, Rajkot, Gujarat, India.Introduction: Spatially resolved metabolic data obtained from Proton Magnetic Resonance Spectroscopy (1 H MRS) provides information which increases the diagnostic accuracy of imaging sequences in predicting the histology of suprasellar tumors. Aim: To evaluate the role of 1 H MRS in the diagnosis of various suprasellar tumors. Materials and Methods: Sixty cases of various suprasellar, hypothalamic and third ventricular neoplasms were investigated with long-echo single voxel 1 H -MRS using 1.5 Tesla clinical imager. Single-voxel spectroscopic examinations were guided by T1-weighted or T2-weighted images. Statistical analysis was carried out using IBM SPSS software version 19. Results: We observed that whenever brain tissue was damaged or replaced by any process, NAA was markedly reduced. Extraaxial lesions which do not infiltrate brain or contain neuroglial tissue, didn’t demonstrate any NAA resonances. Cr was used as an internal standard for semi-quantitative evaluation of metabolic changes of other brain metabolites. Increased Cho was seen in processes with elevated cell-membrane turnover. Conclusion: Spectra obtained from different tumors exhibit reproducible differences while histologically similar tumors yield characteristic spectra with only minor differences. Pituitary tumors were typically characterized by significant reduction of NAA, Cr peak and moderate elevation of Cho peak. Gliomas were typically characterized by decrease of NAA and Cr peaks and increase of Cho peak. Craniopharyngiomas were typically characterized by significant decrease of all metabolites.https://jcdr.net/articles/PDF/8078/17988_CE[Ra]_F(P)_Reformat_PF2(PAG)_PFA(P).pdfcholinecreatinen-acetylaspartatespectroscopy
spellingShingle A EINSTIEN
RAHUL A VIRANI
Clinical Relevance of Single-Voxel 1 H Mrs Metabolites in Discriminating Suprasellar Tumors
Journal of Clinical and Diagnostic Research
choline
creatine
n-acetylaspartate
spectroscopy
title Clinical Relevance of Single-Voxel 1 H Mrs Metabolites in Discriminating Suprasellar Tumors
title_full Clinical Relevance of Single-Voxel 1 H Mrs Metabolites in Discriminating Suprasellar Tumors
title_fullStr Clinical Relevance of Single-Voxel 1 H Mrs Metabolites in Discriminating Suprasellar Tumors
title_full_unstemmed Clinical Relevance of Single-Voxel 1 H Mrs Metabolites in Discriminating Suprasellar Tumors
title_short Clinical Relevance of Single-Voxel 1 H Mrs Metabolites in Discriminating Suprasellar Tumors
title_sort clinical relevance of single voxel 1 h mrs metabolites in discriminating suprasellar tumors
topic choline
creatine
n-acetylaspartate
spectroscopy
url https://jcdr.net/articles/PDF/8078/17988_CE[Ra]_F(P)_Reformat_PF2(PAG)_PFA(P).pdf
work_keys_str_mv AT aeinstien clinicalrelevanceofsinglevoxel1hmrsmetabolitesindiscriminatingsuprasellartumors
AT rahulavirani clinicalrelevanceofsinglevoxel1hmrsmetabolitesindiscriminatingsuprasellartumors